Additional monitoring and analysis are always needed, as with any medical treatment. Depression can be a fatal illness, so avoiding effective treatment until the field is more "mature" may cost lives.
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial https://pubmed.ncbi.nlm.nih.gov/29728331/
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up https://pubmed.ncbi.nlm.nih.gov/29119217/
Here's a counter-example to my claim, FYI. Trial of Psilocybin versus Escitalopram for Depression https://www.nejm.org/doi/10.1056/NEJMoa2032994